CYTEK BIOSCIENCES, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CYTEK BIOSCIENCES, INC. (CTKB) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $1.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $646.00K.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was -$1.23M, a 172.45% decline year-over-year.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $1.70M.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$1.09M.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $109.00K, a 97.59% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $4.53M.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$1.45M.
- CYTEK BIOSCIENCES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$2.49M, a 291.17% decline from fiscal 2021.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $646.00K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $109.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$1.30M 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | -$2.15M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$1.23M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $4.53M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $3.01M 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $3.96M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$1.45M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$622.00K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$2.10M 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | -$1.09M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$2.49M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$1.49M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$1.62M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$216.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $1.30M 10-K · filed 2024-03-13 | |||
| 2021-09-30 | $625.00K 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $631.00K 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $481.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$587.00K 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$13.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $283.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |